Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives

Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives

Xiongwen Ran, Kai Yang Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China Abstract: Head and neck cancer (HNC) is a common malignant tumor, but traditional therapeutic methods have unsatisfac...

Full description

Bibliographic Details
Main Authors: Ran X, Yang K
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Drug Design, Development and Therapy
Subjects:
Head and neck cancer
Squamous cell carcinoma
programmed cell death 1
programmed cell death ligand 1
Immunotherapy
Online Access:https://www.dovepress.com/inhibitors-of-the-pd-1pd-l1-axis-for-the-treatment-of-head-and-neck-ca-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/inhibitors-of-the-pd-1pd-l1-axis-for-the-treatment-of-head-and-neck-ca-peer-reviewed-article-DDDT

Similar Items